Morepen Laboratories Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Morepen Laboratories (MOREPENLAB) Key Ratios
Morepen Laboratories Share Price Analysis Local DB
Morepen Laboratories share price is ₹103.65, day high (share price) is ₹110.50, day low (share price) is ₹100.10 and volume is 24,688,972. 52 Week high share price for Morepen Laboratories is ₹110.50 on 01 Sep 2026 and 52 week low share price for Morepen Laboratories is ₹33.05 on 30 Mar 2026. Price data as of: 01 Sep, 2026 3:31 PM.
According to latest price data (as of 01 Sep, 2026 3:31 PM) for Morepen Laboratories share, 14 day period RSI (Relative Strength Index) is 74.4 (O.Bought), 50 DMA (50 Displaced Moving Average) is 70.73 and 200 DMA (200 Displaced Moving Average) is 48.80.
Morepen Laboratories (MOREPENLAB) Technical Analysis
Morepen Laboratories Technical Data and Analysis available in multiple timeframes.
Morepen Laboratories Oscillators Analysis
Morepen Laboratories Price Action
Morepen Laboratories Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 74.44 |
| Stoch %K (14, 3, 3) | 90.81 |
| CCI (20) | 122.61 |
| ADX (14) | 57.70 |
| Awesome Osc | 25.44 |
| Momentum (10) | 15.21 |
| MACD (12, 26, 9) | 10.31 |
| MACD Signal | 9.36 |
| Stoch RSI (14) | 77.32 |
| Williams %R (14) | -18.53 |
| Bull/Bear Power | 20.06 |
| Ultimate Osc | 61.92 |
| MFI (14) | 88.58 |
| ROC (21) | 79.79 |
| ROC (125) | 132.14 |
| ATR (14) | 5.82 |
Morepen Laboratories Moving Averages
| Ichimoku Base | 82.75 | Above Base |
| VWMA (20) | 87.41 | Above VWMA |
| HMA (9) | 107.05 | Below HMA |
Morepen Laboratories Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- RSI is overbought, which may increase the likelihood of short-term consolidation or pullback.
Morepen Laboratories Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 120.05 | 120.45 | 109.60 | 115.21 |
| Resistance 2 | 115.21 | 115.42 | 108.78 | 111.83 |
| Resistance 1 | 111.19 | 111.59 | 107.97 | 109.74 |
| Pivot Point | 106.35 | 106.56 | 107.16 | 106.35 |
| Support 1 | 102.33 | 102.73 | 106.35 | 102.97 |
| Support 2 | 97.49 | 97.70 | 105.54 | 100.88 |
| Support 3 | 93.47 | 93.87 | 104.72 | 97.49 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Morepen Laboratories - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 35.65% | 35.65% | 35.65% | 35.65% |
| FII | 1.46% | 1.59% | 1.62% | 1.62% |
| DII (Other) | 1.28% | 1.25% | 1.25% | 1.49% |
| Retail & Others | 61.60% | 61.51% | 61.47% | 61.23% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
Morepen Laboratories - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 1,827.00 -0.16% | 119.92 -22.69% | 95.65 -18.95% |
| Mar 2025 | 1,829.94 +7.37% | 155.11 +14.54% | 118.02 +22.15% |
| Mar 2024 | 1,704.40 +19.72% | 135.42 +142.86% | 96.62 +149.79% |
| Mar 2023 | 1,423.66 | 55.76 | 38.68 |
Morepen Laboratories - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 29 Aug 2025 | ₹0.2 | View Details |
|
Announcement date
12 May 2025
Ex dividend date
29 Aug 2025
Record date
30 Aug 2025
Dividend type
Final
Amount
0.2
Dividend %
10.0
Details
Rs.0.2000 per share(10%)Final Dividend
|
|||
